More Diabetes Information and Resources:

Diabetes News From Medical News Today
Latest Diabetes News From Medical News Today.

• Researchers Reveal What Makes The Heart 'Tick-Tock'
  Posted on 3 Dec 2008 at 8:00am
  Researchers have new evidence to show that the heart beats to its own drummer, according to a report in the December issue of the journal Cell Metabolism, a Cell Press publication. They've uncovered some of the molecular circuitry within the cardiovascular system itself that controls the daily rise and fall of blood pressure and heart rate. The findings might also explain why commonly used diabetes drugs come with cardiovascular benefits, according to the researchers.
  
• Secreted Protein Sends Signal That Fat Is On The Way
  Posted on 3 Dec 2008 at 7:00am
  After you eat a burger and fries or other fat-filled meal, a protein produced by the liver may send a signal that fat is on the way, suggests a report in the December issue of the journal Cell Metabolism, a Cell Press publication. Researchers have found in mice that the liver produces a protein called adropin, which rises in response to high-fat foods and falls after fasting.
  
• Lack Of Vitamin D Could Spell Heart Trouble
  Posted on 3 Dec 2008 at 3:00am
  Vitamin D deficiency - which is traditionally associated with bone and muscle weakness - may also increase the risk of cardiovascular disease (CVD). A growing body of evidence links low 25-hydroxyvitamin D levels to common CVD risk factors such as hypertension, obesity and diabetes, as well as major cardiovascular events including stroke and congestive heart failure.
  
• Diamyd Medical: Diamyd(R) Diabetes Vaccine - Three Blockbuster Indications
  Posted on 2 Dec 2008 at 9:00am
  As reported in New England Journal of Medicine (Oct 30, 2008), Diamyd® preserves insulin producing beta cells best in patients recently diagnosed with the disease. Beta cell destruction is a consecutive process, eventually leading to the need for life-long treatment with insulin. Diamyd® given before clinical presentation could hence prevent the onset of the disease.
  
• Genaera Begins Phase 1b Trial Of Trodusquemine (MSI-1436) In Overweight And O...
  Posted on 2 Dec 2008 at 2:00am
  Genaera Corporation (Nasdaq: GENR) announced that dosing of subjects has begun in study MSI-1436C-102 (Study 102), the multiple ascending dose Phase 1b study of trodusquemine (MSI-1436) in overweight and obese type 2 diabetics. MSI-1436 is a novel therapeutic for the treatment of type 2 diabetes and obesity which works centrally and peripherally to regulate insulin and leptin pathways through the highly selective inhibition of its novel target enzyme, PTP-1B.